170 related articles for article (PubMed ID: 2833543)
1. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline.
Den Boer JA; Westenberg HG
Int Clin Psychopharmacol; 1988 Jan; 3(1):59-74. PubMed ID: 2833543
[TBL] [Abstract][Full Text] [Related]
2. Serotonin-influencing drugs in the treatment of panic disorder.
Westenberg HG; den Boer JA
Psychopathology; 1989; 22 Suppl 1():68-77. PubMed ID: 2498967
[TBL] [Abstract][Full Text] [Related]
3. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
den Boer JA; Westenberg HG; Kamerbeek WD; Verhoeven WM; Kahn RS
Int Clin Psychopharmacol; 1987 Jan; 2(1):21-32. PubMed ID: 3117876
[TBL] [Abstract][Full Text] [Related]
4. Panic attacks and agoraphobia: low dose clomipramine treatment.
Gloger S; Grunhaus L; Gladic D; O'Ryan F; Cohen L; Codner S
J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
[TBL] [Abstract][Full Text] [Related]
5. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine.
den Boer JA; Westenberg HG; De Leeuw AS; van Vliet IM
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():47-52. PubMed ID: 7622824
[TBL] [Abstract][Full Text] [Related]
6. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
Kasper S; Voll G; Vieira A; Kick H
Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
[TBL] [Abstract][Full Text] [Related]
7. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
[TBL] [Abstract][Full Text] [Related]
8. Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.
Nolen WA; van de Putte JJ; Dijken WA; Kamp JS; Blansjaar BA; Kramer HJ; Haffmans J
Acta Psychiatr Scand; 1988 Dec; 78(6):668-75. PubMed ID: 3146890
[TBL] [Abstract][Full Text] [Related]
9. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
Den Boer JA; Westenberg HG
Psychopharmacology (Berl); 1990; 102(1):85-94. PubMed ID: 1697419
[TBL] [Abstract][Full Text] [Related]
10. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
Lesser IM; Rubin RT; Pecknold JC; Rifkin A; Swinson RP; Lydiard RB; Burrows GD; Noyes R; DuPont RL
Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
[TBL] [Abstract][Full Text] [Related]
11. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo.
Evans L; Kenardy J; Schneider P; Hoey H
Acta Psychiatr Scand; 1986 Jan; 73(1):49-53. PubMed ID: 2938422
[TBL] [Abstract][Full Text] [Related]
12. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
Munjack DJ; Crocker B; Cabe D; Brown R; Usigli R; Zulueta A; McManus M; McDowell D; Palmer R; Leonard M
J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone.
Pohl R; Balon R; Yeragani VK; Gershon S
Psychopathology; 1989; 22 Suppl 1():60-7. PubMed ID: 2657839
[TBL] [Abstract][Full Text] [Related]
14. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
Lesser IM; Rubin RT; Rifkin A; Swinson RP; Ballenger JC; Burrows GD; Dupont RL; Noyes R; Pecknold JC
J Affect Disord; 1989; 16(1):49-58. PubMed ID: 2521651
[TBL] [Abstract][Full Text] [Related]
15. Platelet serotonin uptake in panic disorder: comparison with normal controls and the effect of treatment.
Norman TR; Gregory MS; Judd FK; Burrows GD; McIntyre IM
Aust N Z J Psychiatry; 1988 Dec; 22(4):390-5. PubMed ID: 2907288
[TBL] [Abstract][Full Text] [Related]
16. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
Emrich HM; Berger M; Riemann D; von Zerssen D
Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
[TBL] [Abstract][Full Text] [Related]
17. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
Swinson RP; Pecknold JC; Kuch K
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823
[TBL] [Abstract][Full Text] [Related]
18. Apathy and indifference in patients on fluvoxamine and fluoxetine.
Hoehn-Saric R; Lipsey JR; McLeod DR
J Clin Psychopharmacol; 1990 Oct; 10(5):343-5. PubMed ID: 2124218
[TBL] [Abstract][Full Text] [Related]
19. Serotonin antagonism in panic disorder: an open trial with ritanserin.
Griez E; Pols H; Lousberg H
Acta Psychiatr Belg; 1988; 88(5-6):372-7. PubMed ID: 3152708
[TBL] [Abstract][Full Text] [Related]
20. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
Servant D; Bailly D; Le Seac'h H; Parquet PJ
Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
